Literature DB >> 16973671

Stochastic modelling of colon cancer: is there a role for genomic instability?

Mark P Little1, Guangquan Li.   

Abstract

Three stochastic models of genomic instability recently developed by Little and Wright (Math. Biosci., (2003) 183, 111-34), with two, three and five stages, and the two-stage genomic instability model of Nowak et al. (Proc. Natl Acad. Sci. USA, (2002) 99, 16226-16231) are compared with the four-stage model proposed by Luebeck and Moolgavkar (Proc. Natl Acad. Sci. USA, (2002) 99, 15095-15100) that does not assume such an instability mechanism. All models are fitted to US colon cancer incidence data. The best fitting models are the two-stage model of Nowak et al. and the two-stage model of Little and Wright, with the four-stage model of Luebeck and Moolgavkar not markedly inferior. The fits of the three-stage and five-stage models are somewhat worse (P<0.05), the five-stage model fitting particularly poorly (P<0.01). Both optimal genomic instability models predict cellular mutation rates that are at least 10 000 times higher after genomic destabilization, for both sexes. Therefore, the results of this paper are somewhat at variance with those of previous analyses of Little and Wright in suggesting that equivalently good fit may be obtained by models that do not assume a role for genomic destabilization in the induction of colon cancer as for those that do.

Entities:  

Mesh:

Year:  2006        PMID: 16973671     DOI: 10.1093/carcin/bgl173

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  24 in total

1.  Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.

Authors:  J C Kaiser; P Jacob; R Meckbach; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2011-09-23       Impact factor: 1.925

2.  Comparison of mortality and incidence solid cancer risk after radiation exposure in the Techa River Cohort.

Authors:  M Eidemüller; E Ostroumova; L Krestinina; S Epiphanova; A Akleyev; P Jacob
Journal:  Radiat Environ Biophys       Date:  2010-05-12       Impact factor: 1.925

3.  A new view of radiation-induced cancer.

Authors:  I Shuryak; R K Sachs; D J Brenner
Journal:  Radiat Prot Dosimetry       Date:  2010-11-27       Impact factor: 0.972

4.  Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.

Authors:  Paolo Boffetta; Deborah M Winn; John P Ioannidis; Duncan C Thomas; Julian Little; George Davey Smith; Vincent J Cogliano; Stephen S Hecht; Daniela Seminara; Paolo Vineis; Muin J Khoury
Journal:  Int J Epidemiol       Date:  2012-05-16       Impact factor: 7.196

5.  Cancer risks after radiation exposure in middle age.

Authors:  Igor Shuryak; Rainer K Sachs; David J Brenner
Journal:  J Natl Cancer Inst       Date:  2010-10-25       Impact factor: 13.506

6.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-05       Impact factor: 1.925

7.  A new stochastic and state space model of human colon cancer incorporating multiple pathways.

Authors:  Wai Y Tan; Xiao W Yan
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

8.  Parameter identifiability and redundancy: theoretical considerations.

Authors:  Mark P Little; Wolfgang F Heidenreich; Guangquan Li
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

9.  Parameter identifiability and redundancy in a general class of stochastic carcinogenesis models.

Authors:  Mark P Little; Wolfgang F Heidenreich; Guangquan Li
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

10.  Mutator mutations enhance tumorigenic efficiency across fitness landscapes.

Authors:  Robert A Beckman
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.